Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs... Show more
ASRT is expected to report earnings to fall 87.80% to -35 cents per share on July 30
Q2'26
Est.
$-0.36
Q1'26
Missed
by $2.88
Q4'25
Missed
by $0.99
Q3'25
Beat
by $0.27
Q2'25
Beat
by $0.10
The last earnings report on May 08 showed earnings per share of -293 cents, missing the estimate of -5 cents. With 486.53K shares outstanding, the current market capitalization sits at 151.73M.